Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | GPCR |
---|---|---|
09:32 ET | 18757 | 37.4 |
09:34 ET | 11557 | 37.15 |
09:36 ET | 450 | 36.8 |
09:38 ET | 1112 | 36.775 |
09:39 ET | 1200 | 36.745 |
09:41 ET | 4992 | 36.49 |
09:43 ET | 850 | 36.41 |
09:45 ET | 3126 | 36.7 |
09:48 ET | 1120 | 36.6 |
09:50 ET | 800 | 36.64 |
09:52 ET | 1600 | 36.67 |
09:54 ET | 400 | 36.67 |
09:56 ET | 2444 | 36.69 |
09:57 ET | 1737 | 37 |
09:59 ET | 1885 | 37.1 |
10:01 ET | 700 | 37.31 |
10:03 ET | 1427 | 37.2 |
10:06 ET | 800 | 37.26 |
10:08 ET | 1050 | 37.29 |
10:10 ET | 500 | 37.13 |
10:12 ET | 225 | 37.1999 |
10:14 ET | 1535 | 37.35 |
10:15 ET | 4995 | 37.49 |
10:17 ET | 2802 | 37.49 |
10:19 ET | 2937 | 37.27 |
10:21 ET | 1100 | 37.3 |
10:24 ET | 4350 | 37.6 |
10:26 ET | 700 | 37.81 |
10:28 ET | 1847 | 38 |
10:30 ET | 820 | 37.99 |
10:32 ET | 935 | 37.79 |
10:33 ET | 2190 | 37.93 |
10:35 ET | 10677 | 38.21 |
10:37 ET | 1250 | 38.4215 |
10:39 ET | 2496 | 38.45 |
10:42 ET | 6301 | 38.5 |
10:44 ET | 3000 | 38.595 |
10:46 ET | 4072 | 38.5461 |
10:48 ET | 800 | 38.495 |
10:50 ET | 1000 | 38.56 |
10:51 ET | 951 | 38.76 |
10:53 ET | 3391 | 38.79 |
10:55 ET | 2586 | 39.13 |
10:57 ET | 1392 | 39.3 |
11:00 ET | 1023 | 39.38 |
11:02 ET | 1125 | 39.23 |
11:04 ET | 9383 | 39.25 |
11:06 ET | 1490 | 39.4 |
11:08 ET | 3225 | 39.4949 |
11:09 ET | 2825 | 39.265 |
11:11 ET | 2771 | 39.24 |
11:13 ET | 2176 | 39.45 |
11:15 ET | 4152 | 39.44 |
11:18 ET | 5659 | 39.8 |
11:20 ET | 2581 | 39.825 |
11:22 ET | 2450 | 39.745 |
11:24 ET | 401 | 39.655 |
11:26 ET | 4157 | 39.75 |
11:27 ET | 7873 | 39.85 |
11:29 ET | 3374 | 39.78 |
11:31 ET | 1200 | 39.795 |
11:33 ET | 2288 | 39.705 |
11:36 ET | 2711 | 39.69 |
11:38 ET | 1300 | 39.59 |
11:40 ET | 1000 | 39.53 |
11:42 ET | 3201 | 39.72 |
11:44 ET | 1350 | 39.695 |
11:45 ET | 800 | 39.64 |
11:47 ET | 596 | 39.54 |
11:49 ET | 571 | 39.56 |
11:51 ET | 706 | 39.7291 |
11:54 ET | 700 | 39.5101 |
11:56 ET | 5200 | 39.685 |
11:58 ET | 518 | 39.7351 |
12:00 ET | 525 | 39.685 |
12:02 ET | 200 | 39.76 |
12:03 ET | 2339 | 39.46 |
12:05 ET | 1850 | 39.285 |
12:07 ET | 700 | 39.21 |
12:09 ET | 1321 | 39.225 |
12:12 ET | 400 | 39.3042 |
12:14 ET | 2572 | 39.125 |
12:16 ET | 2000 | 39.04 |
12:18 ET | 1400 | 38.88 |
12:20 ET | 1200 | 38.86 |
12:23 ET | 989 | 38.795 |
12:25 ET | 2352 | 38.62 |
12:27 ET | 850 | 38.665 |
12:30 ET | 4502 | 38.5018 |
12:32 ET | 300 | 38.594 |
12:34 ET | 12436 | 38.685 |
12:36 ET | 879 | 38.82 |
12:38 ET | 1050 | 38.695 |
12:39 ET | 200 | 38.835 |
12:41 ET | 200 | 38.915 |
12:43 ET | 3752 | 38.81 |
12:45 ET | 2262 | 38.95 |
12:48 ET | 100 | 38.85 |
12:52 ET | 436 | 38.9099 |
12:54 ET | 819 | 38.775 |
12:56 ET | 609 | 38.7712 |
12:57 ET | 1523 | 38.82 |
12:59 ET | 1400 | 38.69 |
01:01 ET | 12616 | 38.99 |
01:03 ET | 32872 | 39.305 |
01:06 ET | 550 | 39.38 |
01:08 ET | 7823 | 39.505 |
01:10 ET | 1100 | 39.34 |
01:12 ET | 1000 | 39.26 |
01:14 ET | 1720 | 39.255 |
01:15 ET | 750 | 39.2558 |
01:17 ET | 3249 | 39.35 |
01:19 ET | 100 | 39.43 |
01:21 ET | 400 | 39.42 |
01:24 ET | 500 | 39.43 |
01:26 ET | 3100 | 39.375 |
01:28 ET | 961 | 39.46 |
01:30 ET | 800 | 39.485 |
01:32 ET | 4300 | 39.38 |
01:33 ET | 1600 | 39.25 |
01:35 ET | 2442 | 39.195 |
01:37 ET | 3803 | 39.16 |
01:39 ET | 1485 | 39.14 |
01:42 ET | 850 | 39.16 |
01:44 ET | 300 | 39.15 |
01:46 ET | 1300 | 39.18 |
01:48 ET | 600 | 39.27 |
01:50 ET | 1600 | 39.22 |
01:51 ET | 100 | 39.33 |
01:53 ET | 2400 | 39.16 |
01:55 ET | 1984 | 38.86 |
01:57 ET | 300 | 38.795 |
02:00 ET | 15200 | 38.71 |
02:02 ET | 9117 | 38.76 |
02:04 ET | 1169 | 38.68 |
02:06 ET | 1095 | 38.5 |
02:08 ET | 300 | 38.7599 |
02:09 ET | 1543 | 38.66 |
02:13 ET | 100 | 38.75 |
02:15 ET | 200 | 38.8 |
02:18 ET | 16942 | 39.11 |
02:20 ET | 3961 | 39.11 |
02:22 ET | 1200 | 38.99 |
02:24 ET | 3000 | 38.98 |
02:26 ET | 100 | 38.87 |
02:27 ET | 800 | 38.94 |
02:29 ET | 300 | 38.855 |
02:33 ET | 509 | 38.68 |
02:36 ET | 600 | 38.68 |
02:40 ET | 2254 | 38.83 |
02:42 ET | 700 | 38.98 |
02:44 ET | 400 | 39.05 |
02:45 ET | 32447 | 39.055 |
02:47 ET | 8580 | 38.945 |
02:49 ET | 18273 | 38.615 |
02:51 ET | 1661 | 38.5 |
02:54 ET | 2373 | 38.44 |
02:56 ET | 902 | 38.5 |
02:58 ET | 900 | 38.67 |
03:00 ET | 100 | 38.6 |
03:02 ET | 1600 | 38.75 |
03:03 ET | 2600 | 39.06 |
03:05 ET | 400 | 39.12 |
03:07 ET | 600 | 39.07 |
03:09 ET | 2833 | 39.35 |
03:12 ET | 2450 | 39.08 |
03:14 ET | 1100 | 38.985 |
03:16 ET | 100 | 38.88 |
03:20 ET | 590 | 38.73 |
03:21 ET | 1707 | 38.72 |
03:23 ET | 100 | 38.73 |
03:25 ET | 200 | 38.64 |
03:27 ET | 1585 | 38.645 |
03:30 ET | 10970 | 38.67 |
03:32 ET | 200 | 38.65 |
03:34 ET | 19828 | 38.495 |
03:36 ET | 3150 | 38.66 |
03:38 ET | 1200 | 38.7 |
03:39 ET | 512 | 38.66 |
03:41 ET | 1728 | 38.735 |
03:43 ET | 1862 | 38.54 |
03:45 ET | 3152 | 38.615 |
03:48 ET | 484 | 38.56 |
03:50 ET | 3072 | 38.43 |
03:52 ET | 2007 | 38.355 |
03:54 ET | 1590 | 38.29 |
03:56 ET | 31380 | 38.59 |
03:57 ET | 17745 | 38.385 |
03:59 ET | 25753 | 38.32 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Structure Therapeutics Inc | 1.7B | -16.5x | --- |
Edgewise Therapeutics Inc | 1.7B | -11.3x | --- |
Kura Oncology Inc | 1.7B | -9.9x | --- |
Syndax Pharmaceuticals Inc | 1.8B | -6.2x | --- |
Inhibrx Inc | 1.8B | -6.4x | --- |
Sana Biotechnology Inc | 1.8B | -5.2x | --- |
Structure Therapeutics Inc. is a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for metabolic and cardiopulmonary diseases. It is focused on G-protein coupled receptors (GPCRs) as a therapeutic target class. Its product candidates include GSBR-1290, Amylin, glucose-dependent insulinotropic polypeptide receptor (GIPR), GCGR, ANPA-0073 and LTSE-2578. It is developing GSBR-1290, its oral small molecule product candidate targeting the validated glucagon-like-peptide-1 receptor (GLP-1R) for the treatment of type 2 diabetes mellitus (T2DM) and obesity. It is developing GLP-1R candidates, including dual GLP-1R/GIPR agonists and amylin agonists, each designed with customized properties to achieve additional benefit. It is developing ANPA-0073, an investigational oral small molecule APJR agonist, for the treatment of idiopathic pulmonary fibrosis (IPF). It is evaluating its LPA1R program, LTSE-2578 for IPF and progressive pulmonary fibrosis.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $1.7B |
---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 46.6M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-2.32 |
Book Value | $9.76 |
P/E Ratio | -16.5x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.